查看文章

Acute right ventricular failure is one of the most dreaded complications following left ventricular assist device (LVAD) implantation. The most established treatment for this disease pattern is the implantation of a temporary paracorporeal right ventricular assist device (RVAD). Currently, in our institution, three different ECLS pump configurations are established and randomly deployed based on their availability. We sought to assess differences between these three systems regarding mortality, bleeding complications, and postoperative length of stay at the intensive care unit.

The study was designed as a monocentric, retrospective case-control study. All patients receiving LVAD with paracorporeal RVAD between 2009 and 2020 were included, and three patient groups were formed (A: Centrifugal pump, B: Rotary pump, C: Compact pump).

A total of 245 patients were included. Preoperative …